Technology | May 08, 2015

Pie Medical Imaging Upgrades 3mensio Structural Heart Planning Platform

New workflows enable advanced visualization for mitral valve replacement, other structural heart interventions

Pie Medical Imaging, 3mensio Structural Heart, mitral, septal crossing, workflow

May 8, 2015 — Pie Medical Imaging announces its new release of 3mensio Structural Heart, dedicated to planning of structural heart interventions. This new release contains an optimized Mitral workflow and a new Septal Crossing workflow for planning of mitral valve procedures to determine the appropriate access route based on computed tomography (CT) images. These new innovations will be shown at the EuroPCR in Paris, May 19- 22.

More insight on the size and shape of the mitral valve is vital for pre-procedural planning of mitral valve replacement and repair procedures. The Mitral workflow provides advanced visualization and sizing of the mitral annulus and its surrounding structures like the aortic valve and coronary arteries. Also the possible impact on the left ventricular outflow tract (LVOT) clearance of placing a valve can be simulated.
 
The Septal Crossing workflow enables visualization of cardiac structures in a simulated angioview. In this simulated angioview, anatomic relations between the interatrial septum, left atrial appendage (LAA) ostium, mitral annulus and vena cava can be easily determined.

For more information: www.piemedicalimaging.com


Additional Content

News | Heart Valve Technology

Oct. 29, 2026 — Abbott has initiated the CROWN-MV pivotal trial evaluating the safety and effectiveness of its ...

Home November 05, 2026
Home
News | Heart Valve Technology

Oct. 21, 2026 — Edwards Lifesciences Corp. recently announced that the U.S. Food and Drug Administration (FDA) has ...

Home October 23, 2026
Home
News | Heart Valve Technology

Sept. 22, 2026 — Following transcatheter aortic valve implantation (TAVI), disturbances in the heart’s electrical ...

Home September 25, 2026
Home
News | Heart Valve Technology

Sept. 22, 2026 — Researchers at the Icahn School of Medicine at Mount Sinai have received a $3.6 million, four-year ...

Home September 24, 2026
Home
News | Heart Valve Technology

June 29, 2026 — Laplace Interventional recently announced that the U.S. Food and Drug Administration (FDA) has approved ...

Home July 02, 2026
Home
Subscribe Now